Concepedia

Petar Jelinic

PJ

21

Publications

1.8K

Citations

15

H-Index

2006

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

NYU Langone Health

Merck & Co., Inc., Rahway, NJ, USA (United States)

Barts Health NHS Trust

Dana-Farber Cancer Institute

Petar Jelinic is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and chromatin.

ORCID

Top concepts

Publications per year

2006–2024

21

Publications

21

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary

Petar Jelinic, Jennifer J. Mueller, Narciso Olvera et al. · Nature Genetics · 2014 · 371 citations · Full text

, , +7

Homologous Recombination Deficiency: Concepts, Definitions, and Assays

Mark Stewart, Diana Merino Vega, Rebecca C. Arend et al. · The Oncologist · 2022 · 207 citations · Full text

The Testis-Specific Factor CTCFL Cooperates with the Protein Methyltransferase PRMT7 in H19 Imprinting Control Region Methylation

Petar Jelinic, Jean-Christophe Stehle, Phillip Shaw · PLoS Biology · 2006 · 197 citations · Full text

Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade

Petar Jelinic, Jacob Ricca, Elke Van Oudenhove et al. · JNCI Journal of the National Cancer Institute · 2017 · 156 citations · Full text

CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary

Yibo Xue, Brian Meehan, Elizabeth A. Macdonald et al. · Nature Communications · 2019 · 110 citations · Full text

Rows per page

1–5 of 21